0

Construction, Expression, and Function of 6B11ScFv-mIL-12, a Fusion Protein That Attacks Human Ovarian Carcinoma

Hongyan Cheng, Xue Ye, Xiaohong Chang, Ruiqiong Ma, Xu Cong, Yidong Niu, Menglei Zhang, Kai Liu, Heng Cui, Jianli Sang

Med Oncol. 2015 Apr;32(4):130.

PMID: 25794492

Abstract:

We previously produced an anti-idiotypic monoclonal antibody, 6B11, which mimics ovarian cancer antigen CA166-9 and induces cellular and humoral immunity. Here, to enhance the immunogenicity of 6B11, we constructed the 6B11ScFv-mIL-12 fusion protein (FP), by fusing single-chain fragment of 6B11 variable region (6B11ScFv) with mouse interleukin-12 (mIL-12), which was expressed in eukaryotic 293EBNA cells transfected with pSBI vectors. A binding activity assay showed 6B11ScFv-mIL-12 to have activities of both 6B11 and mIL-12-it specifically bound both ovarian monoclonal antibody COC166-9 and rabbit anti-mouse IL-12 antibody. The immune activity assay showed 6B11ScFv-mIL-12 to promote proliferation of lymphocytes stimulated by phytohemagglutinin, increase the absolute numbers and percentages of CD3(-)/CD56(+) natural killer cells and CD3(+)/CD56(+) natural killer T cells among peripheral lymphocytes, and increase interferon-γ. The FP was specifically cytotoxic to the CA166-9(+) ovarian cancer cell lines HOC1A and SKOV3 and inhibited growth of ID8 subcutaneous tumors in C57BL/6J mice. This study provides an experimental basis for clinical use of 6B11ScFv-mIL-12 in ovarian cancer therapy. To our knowledge, this is the first report of a fusion protein from an anti-idiotypic antibody and IL-12.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
IAR4248504 Anti-CD3, T Cell antibody produced in rabbit Anti-CD3, T Cell antibody produced in rabbit Price
qrcode